CART-19 cells

CAR-T cell therapy targeting CD19 · Fujian Medical University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CART-19 cells, covering 2017-01-23 to 2017-04-05. Get the full timeline:

Most recent: Clinical Trial Update: The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Lymphoma [Phase 1]